Network analysis using STRING [35] shows that TP53 inhibits FOSL1, SPHK1, ICAM5, and MSLN. In addition, our results suggest that TP53 may also inhibit other TP53-MSN genes, and that TP53 mutations may contribute to their elevated expression in a number of different cancer types. This evidence concerns the gene MSN and cancer.